chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large 5cmx5cm area of erythema, edema, discoloration of skin, left upper arm (deltoid).  Follow-up information received - Adverse Event Onset Date/Time 1-4-07 - Seen in office 1-29-07.
Erythema, warmth and induration inferior and posterior to deltoid muscle, worsening each day until came in 1/16/2014.  Rx cephalexin with resolution.
10 days later fatigue, muscle aches, fever, sore arm and mild rash.
Approximately eight months post vax pt was diagnosed with chickenpox with vaccine failure. It was reported that she had one lesion and then the next day had greater than 100 lesions and a fever of 101F. She was seen by a physician on 11/15/1999.
vomited the 4th capsule 12 hrs p/taking it; no therapy was initiated;
A healthcare professional reported that a pt received an injection of Pnu-Imune 23 and subsequently developed an injection site reaction characterized by redness, swelling and warmth. No further information was available at the date of this report. The reporter indicated that 2 pts experienced this event; however, they are not presently identifiable. An additional report will be generated when identifying information is provided.
Weakness in left side of body, loss of mobility and reflexes. Seizure like tremors lasted 4 days
I started with dry cough on 9/30/2021, around 12pm to 1pm, cough not productive. I'd coughed one to three times and then it would stop. Gone by time I went to bed that night. Also had a sore left shoulder.
22 months at onset of adverse event. Pt presented to ED with right sided facial drooping x 24 hours 1/27/10 pt. followed up with primary care doctor. ED started 14 day course of steroid taper and acyclovir x 10 days. Symptoms resolved over next few weeks. Final diagnosis was Bell's Palsy.
Mom woke pt up to come for vaccines (HPV & Flu shot).  Pt had pretzels for breakfast.  After giving vaccines pt looked fine & asked for a popsicle when offered.  RN was coming back with popsicle when brother came out of room asking for help because pt's arms, legs & feet were shaking.  Pt told mom & brother prior to this that she felt funny.  After event pt sd she was dreaming.  Pt wanted to know what happened.  Mom was in front of pt who was sitting in chair where vaccines were given.  Helped pt to exam table after shaking stopped.  Checked VS.  MD examined pt.  Pt was awake the whole time.  She did look pale during event.  Her coloring returned.  Checked on pt later in day.  Spoke to dad who sd pt was doing better & resting.
Information has been received from a registered nurse concerning a 7-year-old female with a history of impetigo and no known drug allergies, who on 13-DEC-1996 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccines administered that day included a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD), a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, and a dose of poliovirus vaccine inactivated (Vero) (IPOL). It was reported that on 20-JUL-2000 the patient developed shingles rash of the face. Unspecified medical attention was sought and not treatment was required. Subsequently, on an unspecified date, the patient recovered. No product quality complaint was involved. Additional information is not expected.
My right arm was limp the next morning and very painful. i had to take my left arm and move it. I didn't rub or massage it at al I tried to lift the arm by flapping them. It stayed like that for a couple weeks and the pain lessened. however, It still throbs at night and occasionally I will have to help lift that arm. i am right hand dominant but now that arm is weaker than the left. My personal trainer thought it had  limited range of motion, in the right arm with external rotation of the rotator cuff. Also, 90 degree flexion of right arm doing abduction also causes pain.
Information has been received from a patient who "2 months ago",in August 2008 was vaccinated with a dose of ZOSTER vaccine live. Subsequently the patient developed rash at site of administration which lasted 2 or 3 days. The patient wanted to consider taking flu vaccine. At the time of this report , the patient recovered. Additional information was received on 7-OCT-2009 from the patient who stated that he held a degree in chemistry. About 1 day after receiving vaccine he had a warm, tingling sensation at the injection site in a 3 by 3 inch area. The patient did not develop any further symptoms. He used ice for one day and it completely resolved. Additional information has been requested.
CUSTOMER HAD AN APPOINTMENT FOR 6:00 PM 01/07/2022 FOR HER BOOSTER DOSE OF PFIZER COVID 19 VACCINATION. PRIOR TO IMMUNIZING, MOM MENTIONED DAUGHTER HAS HAD FAINTED BEFORE WITH VACCINATIONS (ANTICIPATION OF PAIN OR SOMETIMES WITH PAIN).  HAD HER PLACE BOTH LEGS ON ANOTHER CHAIR (LYING POSITION) BEFORE GIVING THE VACCINE.  AFTER PLACING THE BANDAGE, CUSTOMER STATED SHE FELT VERY NAUSEOUS & FAINTED.  ASKED MOM TO HELP, SHE WOKE UP AFTER FEW MINUTES.  SHE LOOKED PALE & FELT NAUSEOUS. GAVE HER WATER & GATORADE.  CHECKED BP (99/58) & PULSE (67).  OFFERED EMS & EPIPEN (MOM DECLINED). ASKED HER IF SHE FELT ANY TINGLING OR TIGHTNESS AROUND THROAT (NO). MOM & DAD WERE PLANNING TO TAKE HER TO E.R. CALLED PARENTS PRIOR TO PHARMACY CLOSING TO FOLLOW UP ON PATIENT, LEFT MESSAGE TO CONTACT PHARMACY.
Patient came into office 5/27/05, red, hot area at injection site. Area measures 11x9cm.
Initial report was received 20 October 2011 from a consumer, who was also the patient's parent. A two-year-old female patient received a DTAP vaccine (manufacturer, lot number, route and site of administration were unknown) on 04 April 2011, and 161 days after vaccination, the patient had symptoms of an upper respiratory tract infection (URI) and was seen by her doctor on 12 September 2011. She had a nasal swab performed which came back positive for pertussis. An aspirate specimen was not performed. The reporter denied any clinical evidence of pertussis infection. Outcome was not reported and no additional information was provided at the time of the report. Documents held by sender: None.
Arm itched a little bit; Rash; Arm started swelling- in the shot area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Arm itched a little bit), INJECTION SITE RASH (Rash) and INJECTION SITE SWELLING (Arm started swelling- in the shot area) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 21-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Arm itched a little bit), INJECTION SITE RASH (Rash) and INJECTION SITE SWELLING (Arm started swelling- in the shot area). The patient was treated with CORTISONE at an unspecified dose and frequency and CHLORPHENAMINE MALEATE (ANTIHISTAMIN) at an unspecified dose and frequency.   At the time of the report, INJECTION SITE PRURITUS (Arm itched a little bit), INJECTION SITE RASH (Rash) and INJECTION SITE SWELLING (Arm started swelling- in the shot area) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Patient and mother came up to bus, nurse gave patient form to patient?s mother. I was asked by nurse to go grab the CDC card from patient/mother. Took the card from patient?s mother came then back to the bus and filled out CDC card line for 2nd dose. Checked first dose which was Pfizer, asked nurse if the syringe was the proper medication, was given verbal confirmation. Prepared myself for vaccine administration by donning proper PPE and staging equipment. Patient sat down and nurse went over possible side effects. Filled out paperwork. Applied alcohol to injection site, administered dose, documented time of injection. After patient and mother left bus paperwork was handed to team lead who asked, ?wasn?t this a pediatrics?? No adverse reactions presented.
I tested because my husband was positive, and I tested. I only had minor side effects like soreness. I didn't have many symptoms or seek care for my COVID-19 case.
This spontaneous report was received from a licensed vocational nurse (LVN) concerning a patient of unknown age and gender who on an unknown date was vaccinated with a dose of PNEUMOVAX 23, (route, lot number and expiration was not provided). No suspect or concomitant medications were reported. The licensed vocational nurse reported that the patient experienced abnormal injection site swelling and redness after administration of PNEUMOVAX 23. At the time of the report, the patient's outcome was not provided. Additional information has been requested.
I received the vaccine at 12:59 pm and at 1:05 pm my heart began to beat rapidly. I felt heat rush into the left side of my head, I was extremely light headed and couldn?t catch my breath. I asked if there was a nurse that could help me. There was 1 paramedic watching everyone. I stepped outside, took my mask off to catch my breath. One staff member accompanied me and sat next to me. I began to shake in my legs and arms involuntarily, my heart kept beating and I just tried to do deep breathing techniques to catch my breath.  The paramedic came outside and asked if I wanted help. I declined his help and I called my husband who was sitting in the car to help me walk to our car. At 1:15, my heart was beating less rapid, I walked back to the car and as my husband was driving us home, my heart began to beat rapidly again, I felt burning and heat in my head and I began to shake in my arms and legs. It lasted about 10-15 minutes. We got home and I could barely walk into the house because I was so weak in my legs. I went to bed where my heart began beating back to normal after 1 hour or so.
Warm to the touch just below the injection site; Arm was little swollen; Arm was red; Arm sore; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch just below the injection site), VACCINATION SITE PAIN (Arm sore), VACCINATION SITE SWELLING (Arm was little swollen) and VACCINATION SITE ERYTHEMA (Arm was red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 29-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced VACCINATION SITE PAIN (Arm sore). On 06-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch just below the injection site), VACCINATION SITE SWELLING (Arm was little swollen) and VACCINATION SITE ERYTHEMA (Arm was red). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch just below the injection site), VACCINATION SITE PAIN (Arm sore), VACCINATION SITE SWELLING (Arm was little swollen) and VACCINATION SITE ERYTHEMA (Arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient 67 years old with past medical history of hyperlipidemia, hypertension, bipolar, arthritis, insomnia, migraine presented to the hospital ED with a chief complaint of sudden onset chest pain that radiated around to the back.  Patient was brought in via EMS.  In route to the ED patient was given nitroglycerin and aspirin.  From the ED charting patient admitted that nitroglycerin has helped relieve the chest pain.  When seen, patient states that the chest pain has resolved currently.  She admitted that was pressure on the chest it did reproduce the pain she was having.  Patient stated that she previously had a stress test early 2021.  She was told at that time that everything looked okay.  When seen, patient was resting in bed comfortably.  She is not having chest pain currently.  Feels fine.  In the ED she tested positive for COVID.  She states she gets intermittent cough from time to time.  Nonproductive.  No other associated symptoms.  Otherwise patient has no fever, chills, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty with urination, dysuria.   In the ED, a decision was made to admit patient for cardiac rule out.  While in the ED patient had a CT PE of the chest that was negative for PE.  According to the ED charting he did show cardiomegaly and CHF. Tested positive for COVID.   Clinical Summary Patient was monitored on telemetry without significant event.  Repeat EKG and CT pulmonary arteries were normal.  Patient has been without chest pain and troponins have been negative.  Chest pain is likely due to COVID.  Patient will be discharged home with instructions to follow up with PCP and cardiology after quarantine period.  No medication changes were made   Discharge diagnosis Chest pain CHF per CT Hypertension COVID positive Hyperlipidemia Mood disorder Admit to MedSurg with telemetry
On 1/30/00, the pt developed a varicella like rash. Diagnosis made by a pediatrician was chicken pox. 100 to 150 lesions were confirmed all over the pt's body. The physician reported that the pt experienced a typical breakthrough varicella rash with one vesicular lesion and the remainder of the rash was non-vesiculated. The pt subsequently recovered. Additional information has been requested.
A non-serious spontaneous report of pregnant woman inadvertently received a dose of H1N1 LAIV was received from a registered nurse/health professional concerning a 16-year-old female. The patient did not have any medical history and she was healthy. The patient did not take any concomitant medications and had refused to take prenatal vitamins. The patient was gravida one and para zero. The patient was 26 weeks pregnant; in her second trimester at the time of vaccination. Her LMP was April or May 2009. The patient's EDD was 17-Feb-2010. On 10-Nov-2009, the patient received H1N1, Intranasal, for an unknown indication. The patient gave birth vaginally, on 20-Feb-2010, to a 7 lb and 5 ozs, baby girl who measured 20 inches long. Both the mother and newborn were well and remained healthy. There was no adverse event associated with this pregnancy therefore, treatment and reporter causality assessments are not applicable, and the event vaccine exposure during pregnancy was considered resolved. Additional information was received on 23-Feb-2010 and incorporated into the narrative: concomitant medications, medical and obstetrical history, LMP, EDD, information about baby and other additional information: patient's age, reporter type, facility address.
Patient became increasingly short of breath and began retaining fluids. He was brought to the ER on 04/05/2022 in Hypertensive Crisis, and directly admitted to the Cardiac Unit, where he was treated for 7 days for CHF.
MRG: Report as COVID 19 death as Xray support the COVID 19 death. Not LTCF; PCR positive 3/2/2021, (-) 3/22/21; S/S: shortness of breath, worsening chest X-rays, diffuse ground-glass infiltrates similar to that of Coronovirus, admitted for managing shortness of breath post fall several week priorl; C/M: CVD - A-fib, heart failure, gout, HTN, COPD - black lung; Dx: ARF with hypoxemia, pneumonia, paroxysmal A-fib, HTN, black lung, acute exacerbation of chronic obstructive airways disease, history of COVID-19, heart failure, Moderna vaccines on 1/12 and 2/8
I received Influenza vaccine at work as recommended by employer at 1030 on 11/2/2007. Approx 1 hr after admin., I began to cough. As the course of the day progressed I became ill. At approx 5:00 pm I was at home and my throat and lungs felt as if they were "closed" I was unable to take a deep breath. Benadryl did not relieve symptoms. I went to ED at LMH and was given Epinephrine via breathing tx . My symptoms were immediately relieved. The ED had me stay for observation afterwards to ensure treatment.effects
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 3:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 3:04 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 48.08 years. No concomitant medications were reported. Batch number 041L20A  underwent temperature excursion on 12-Jan-2021 with temperature 33 degrees Fahrenheit at 09:00 AM. The vial was initially moved to the fridge on 08-Jan-2021 and proposed beyond use date was 07-Feb-2021. Product moved to clinic on 12-Jan-2021. 3 vials were sent to clinic. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
shortly p/vax had high pitched cry alternating w/sleeping spells, cool, clammy, pale skin; temp not taken; leg @ site was tender red like a bee sting; lasted 1 1/2-2 days;
Headache; Chills; Achy; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Achy) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Presents to ED from Nursing home with shortness of breath, found to be COVID postive.Placed on supplementaL O2, BIPAP, Dexamethasone, Remdesivir,Actemra, empiric antibiotics
Sore arm the day of shot, 18 hrs after injection started feeling nauseated. When she left the bathroom, she passed out and fell against the wall. She was taken to a 24 hr. urgent care until transported to hospital and admitted for 2 days. All test came back normal. No cause found.
Severe pain in her upper left arm in the muscle around the injection site.  She has to have help getting dressed. She cannot use this arm for anything and has to use her right arm to lift her left arm.  She has been using rubbing alcohol and muscle rub for the pain.  She contacted her PCP and she was recommended to get 2nd dose but was not given any medical advice.
(L) uppre arm, injection site swelling, hematoma, soreness, discoloration from elbow to shoulder. Painfull to fully extend arm. Still showing symptoms as of Dec 7, 15 medication taken IBU 800 mg every 8 hours from 12-4 till now.
Went to medical center on 12/15/00, after receiving MMR on 12/14/00. Urgent care record: 22 year old student who got unknown vaccine today and now complaining of progressive, diffuse urticaria, post vax, plus itching. No respiratory involvement. Physical exam NAD; mild diffuse urticaria on arms and trunk. No neuro deficit; afebrile. No local redness at injection site.
2 days after recovering vaccine pt. developed wheals on (R) wrist - 10 days after receiving vaccine pt. developed itching & swelling both upper arms.
Feeling terrible; Muscle aches; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included MELOXICAM for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches). At the time of the report, FEELING ABNORMAL (Feeling terrible) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Symptoms began on same day as vaccination, nausea and fatigue.  Next day nausea, vomiting and diarrhea.  Patient made an appointment with her physician on 3-10-2021 and received an prescription for promethazine.  Symptoms resolved by 3-12-2021.
3 days p/vax called by parents due to abn breathing pattern seen in ER-having poss sz activity charaterized by sharp intake of breath, rapid extension of arms, ? of neck followed by brief cry;
Information has been received from a medical assistant concerning a 59 year old male who on 31-JAN-2007 was vaccinated with Pneumovax 23.  On 31-JAN-2007 the patient developed a dark red, painful rash down to the elbow of the inside of his arm (unspecified arm) following vaccination.  The rash did not itch.  The patient was told to take BENADRYL and the symptoms resolved in approximately 6 days.  Additional information has been requested.